KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Work In Process (2016 - 2019)

NovoCure (NVCR) has disclosed Work In Process for 6 consecutive years, with $9.1 million as the latest value for Q2 2019.

  • Quarterly Work In Process rose 73.08% to $9.1 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Jun 2019, up 73.08% year-over-year, with the annual reading at $8.7 million for FY2018, 2.75% up from the prior year.
  • Work In Process hit $9.1 million in Q2 2019 for NovoCure, up from $8.2 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $11.0 million in Q2 2017 to a low of $3.2 million in Q3 2015.
  • Historically, Work In Process has averaged $7.5 million across 5 years, with a median of $8.2 million in 2016.
  • Biggest five-year swings in Work In Process: skyrocketed 260.78% in 2015 and later crashed 51.99% in 2018.
  • Year by year, Work In Process stood at $4.6 million in 2015, then soared by 79.56% to $8.3 million in 2016, then rose by 1.72% to $8.4 million in 2017, then increased by 2.75% to $8.7 million in 2018, then grew by 5.18% to $9.1 million in 2019.
  • Business Quant data shows Work In Process for NVCR at $9.1 million in Q2 2019, $8.2 million in Q1 2019, and $8.7 million in Q4 2018.